LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β

Neuron

Volumn 53, Issue 5, 2007, Pages 703-717

  Peineau, Stéphane ^a   Taghibiglou, Changiz ^b   Bradley, Clarrisa ^b   Wong, Tak Pan ^b   Liu, Lidong ^b   Lu, Jie ^b   Lo, Edmond ^b   Wu, Dongchuan ^b   Saule, Emilia ^a   Bouschet, Tristan ^a   Matthews, Paul ^a   Isaac, John T R ^a,c   Bortolotto, Zuner A ^a   Wang, Yu Tian ^b   Collingridge, Graham L ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

CELLBIO; MOLNEURO

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HIPPOCAMPUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINOPHENOLS; ANIMALS; DENDRITIC SPINES; ENZYME ACTIVATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; LONG-TERM DEPRESSION (PHYSIOLOGY); LONG-TERM POTENTIATION; MALEIMIDES; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, AMPA; SIGNAL TRANSDUCTION;

EID: 33847113902     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2007.01.029     Document Type: Article

References (65)

1. Abraham W.C., and Bear M.F. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci. 19 (1996) 126-130
2. Ali A., Hoeflich K.P., and Woodgett J.R. Glycogen synthase kinase-3: properties, functions, and regulation. Chem. Rev. 101 (2001) 2527-2540
3. Alvarez G., Munoz-Montano J.R., Satrustegui J., Avila J., Bogonez E., and Diaz-Nido J. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. Bipolar Disord. 4 (2002) 153-165
4. Anderson W.W., and Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods 108 (2001) 71-83
5. Anderton B.H. Alzheimer's disease: clues from flies and worms. Curr. Biol. 9 (1999) R106-R109
6. Atkins C.M., Davare M.A., Oh M.C., Derkach V., and Soderling T.R. Bidirectional regulation of cytoplasmic polyadenylation element-binding protein phosphorylation by Ca2+/calmodulin-dependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation. J. Neurosci. 25 (2005) 5604-5610
7. Avila J., Lucas J.J., Perez M., and Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84 (2004) 361-384
8. Bain J., McLauchlan H., Elliott M., and Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371 (2003) 199-204
9. Bear M.F., and Abraham W.C. Long-term depression in hippocampus. Annu. Rev. Neurosci. 19 (1996) 437-462
10. Beasley C., Cotter D., Khan N., Pollard C., Sheppard P., Varndell I., Lovestone S., Anderton B., and Everall I. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci. Lett. 302 (2001) 117-120
11. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., von Zastrow M., and Malenka R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3 (2000) 1291-1300
12. Bhat R.V., Budd Haeberlein S.L., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317
13. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
14. Bolshakov V.Y., and Siegelbaum S.A. Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264 (1994) 1148-1152
15. Bortolotto Z.A., Bashir Z.I., Davies C.H., and Collingridge G.L. A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature 368 (1994) 740-743
16. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee Cox L., et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7 (2000) 793-803
17. Collingridge G.L., Kehl S.J., and McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334 (1983) 33-46
18. Collingridge G.L., Isaac J.T., and Wang Y.T. Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 5 (2004) 952-962
19. Daw M.I., Bortolotto Z.A., Saulle E., Zaman S., Collingridge G.L., and Isaac J.T. Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression. Nat. Neurosci. 5 (2002) 835-836
20. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
21. Dudek S.M., and Bear M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc. Natl. Acad. Sci. USA 89 (1992) 4363-4367
22. Eldar-Finkelman H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 8 (2002) 126-132
23. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 (1980) 519-527
24. Etienne-Manneville S., and Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421 (2003) 753-756
25. Fitzjohn S.M., Bortolotto Z.A., Palmer M.J., Doherty A.J., Ornstein P.L., Schoepp D.D., Kingston A.E., Lodge D., and Collingridge G.L. The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology 37 (1998) 1445-1458
26. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
27. Franco B., Bogdanik L., Bobinnec Y., Debec A., Bockaert J., Parmentier M.L., and Grau Y. Shaggy, the homolog of glycogen synthase kinase 3, controls neuromuscular junction growth in Drosophila. J. Neurosci. 24 (2004) 6573-6577
28. Graef I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., and Crabtree G.R. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401 (1999) 703-708
29. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
30. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., and Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147 (1992) 58-62
31. Hernandez F., Borrell J., Guaza C., Avila J., and Lucas J.J. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J. Neurochem. 83 (2002) 1529-1533
32. Hill M.M., Clark S.F., Tucker D.F., Birnbaum M.J., James D.E., and Macaulay S.L. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19 (1999) 7771-7781
33. Horwood J.M., Dufour F., Laroche S., and Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase Akt cascade in synaptic plasticity and memory in the rat. Eur. J. Neurosci. 23 (2006) 3375-3384
34. Hou L., and Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24 (2004) 6352-6361
35. Huang Y.Y., Colino A., Selig D.K., and Malenka R.C. The influence of prior synaptic activity on the induction of long-term potentiation. Science 255 (1992) 730-733
36. Jiang H., Guo W., Liang X., and Rao Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 120 (2005) 123-135
37. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
38. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., and Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol. Psychiatry 55 (2004) 781-784
39. Kemp N., and Bashir Z.I. Long-term depression: a cascade of induction and expression mechanisms. Prog. Neurobiol. 65 (2001) 339-365
40. Kirschenbaum F., Hsu S.C., Cordell B., and McCarthy J.V. Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276 (2001) 30701-30707
41. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93 (1996) 8455-8459
42. Kozlovsky N., Belmaker R.H., and Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 12 (2002) 13-25
43. Lee Y.I., Seo M., Kim Y., Kim S.Y., Kang U.G., Kim Y.S., and Juhnn Y.S. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 280 (2005) 22044-22052
44. Leost M., Schultz C., Link A., Wu Y.Z., Biernat J., Mandelkow E.M., Bibb J.A., Snyder G.L., Greengard P., Zaharevitz D.W., et al. Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur. J. Biochem. 267 (2000) 5983-5994
45. Leroy K., and Brion J.P. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J. Chem. Neuroanat. 16 (1999) 279-293
46. Li B., Su Y., Ryder J., Yan L., Na S., and Ni B. RIFLE: a novel ring zinc finger-leucine-rich repeat containing protein, regulates select cell adhesion molecules in PC12 cells. J. Cell. Biochem. 90 (2003) 1224-1241
47. Lu W., Man H., Ju W., Trimble W.S., MacDonald J.F., and Wang Y.T. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29 (2001) 243-254
48. Luthi A., Chittajallu R., Duprat F., Palmer M.J., Benke T.A., Kidd F.L., Henley J.M., Isaac J.T., and Collingridge G.L. Hippocampal LTD expression involves a pool of AMPARs regulated by the NSF-GluR2 interaction. Neuron 24 (1999) 389-399
49. Malenka R.C., and Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 44 (2004) 5-21
50. Malinow R., and Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25 (2002) 103-126
51. Malinow R., and Tsien R.W. Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices. Nature 346 (1990) 177-180
52. Man H.Y., Wang Q., Lu W.Y., Ju W., Ahmadian G., Liu L., D'Souza S., Wong T.P., Taghibiglou C., Lu J., et al. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron 38 (2003) 611-624
53. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., and Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243 (1997) 527-536
54. Montgomery J.M., and Madison D.V. State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron 33 (2002) 765-777
55. Morfini G., Szebenyi G., Brown H., Pant H.C., Pigino G., DeBoer S., Beffert U., and Brady S.T. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23 (2004) 2235-2245
56. Mulkey R.M., and Malenka R.C. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9 (1992) 967-975
57. Mulkey R.M., Herron C.E., and Malenka R.C. An essential role for protein phosphatases in hippocampal long-term depression. Science 261 (1993) 1051-1055
58. Mulkey R.M., Endo S., Shenolikar S., and Malenka R.C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369 (1994) 486-488
59. Szatmari E., Habas A., Yang P., Zheng J.J., Hagg T., and Hetman M. A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J. Biol. Chem. 280 (2005) 37526-37535
60. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., Le-Tien H., Fantus I.G., Lewis G.F., and Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J. Biol. Chem. 277 (2002) 793-803
61. Takahashi M., Tomizawa K., Kato R., Sato K., Uchida T., Fujita S.C., and Imahori K. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J. Neurochem. 63 (1994) 245-255
62. Takahashi M., Tomizawa K., and Ishiguro K. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res. 857 (2000) 193-206
63. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., and Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron 38 (2003) 915-928
64. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9 (1990) 2431-2438
65. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., and Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120 (2005) 137-149